Twenty percent of potentially eligible youth are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs), with the ...

Worldwide, breast cancer deaths are projected to increase by 44%, rising to nearly 1.4 million by 2050 from 764,000 in 2023, ...

Vegetarian-associated ESCC risk (HR 1.93) remained robust after excluding the first four follow-up years and restricting to never-smokers, reducing likelihood of reverse causation and smoking ...

Meta-analysis of 64 clinical trials 'should give clinicians and their patients more confidence,' say Hopkins researchers ...

Women tended to lose more weight than men, meta-analysis shows ...

Weight loss triggers biological adaptations, including hormonal shifts, metabolic slowing, neural reward changes, and adipose ...

Characteristics of sarcopenic obesity (SO), including low calf circumference (CC), handgrip strength (HGS) increased  body mass index (BMI) and waist circumference (WC), were associated with an ...

Research presented at AAAAI 2026 suggests GLP-1 RAs may provide clinical benefits for asthma management in patients with excess body weight.

Health officials recommend a good diet, exercise and maintaining a healthy BMI to reduce the risk of heart disease.

Popular GLP-1 receptor agonist drugs (GLP-1 RAs) for weight loss appear to be similarly effective among patients of different ages, races, and starting weight, with women benefiting somewhat more than ...

Since 2010, more than 180 countries have seen rising rates of childhood overweight and obesity, according to World Obesity Federation - Anadolu Ajansı ...

This article explores the intersection between drinking and nutrition to reveal how alcohol-induced malnutrition can ...